It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In magnetic resonance imaging (MRI), the perception of substandard image quality may prompt repetition of the respective image acquisition protocol. Subsequently selecting the preferred high-quality image data from a series of acquisitions can be challenging. An automated workflow may facilitate and improve this selection. We therefore aimed to investigate the applicability of an automated image quality assessment for the prediction of the subjectively preferred image acquisition. Our analysis included data from 11,347 participants with whole-body MRI examinations performed as part of the ongoing prospective multi-center German National Cohort (NAKO) study. Trained radiologic technologists repeated any of the twelve examination protocols due to induced setup errors and/or subjectively unsatisfactory image quality and chose a preferred acquisition from the resultant series. Up to 11 quantitative image quality parameters were automatically derived from all acquisitions. Regularized regression and standard estimates of diagnostic accuracy were calculated. Controlling for setup variations in 2342 series of two or more acquisitions, technologists preferred the repetition over the initial acquisition in 1116 of 1396 series in which the initial setup was retained (79.9%, range across protocols: 73–100%). Image quality parameters then commonly showed statistically significant differences between chosen and discarded acquisitions. In regularized regression across all protocols, ‘structured noise maximum’ was the strongest predictor for the technologists’ choice, followed by ‘N/2 ghosting average’. Combinations of the automatically derived parameters provided an area under the ROC curve between 0.51 and 0.74 for the prediction of the technologists’ choice. It is concluded that automated image quality assessment can, despite considerable performance differences between protocols and anatomical regions, contribute substantially to identifying the subjective preference in a series of MRI acquisitions and thus provide effective decision support to readers.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Diagnostic and Interventional Radiology, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203)
2 Ludwig Maximilians University, Faculty of Medicine, Chair of Epidemiology, Institute of Medical Information Processing, Biometry and Epidemiology, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Epidemiology, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Partner Site Munich Heart Alliance, German Centre for Cardiovascular Research (DZHK), Munich, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237)
3 Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany (GRID:grid.428590.2) (ISNI:0000 0004 0496 8246)
4 University of Würzburg, Institute for Clinical Epidemiology and Biometry, Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); Charité – Universitätsmedizin Berlin, Institute of Social Medicine, Epidemiology and Health Economics, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662); Bavarian Health and Food Safety Authority, State Institute of Health, Erlangen, Germany (GRID:grid.414279.d) (ISNI:0000 0001 0349 2029)
5 Charité – Universitätsmedizin Berlin, Institute of Social Medicine, Epidemiology and Health Economics, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662)
6 University Hospital Essen, University of Duisburg-Essen, Institute for Medical Informatics, Biometry and Epidemiology, Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445)
7 Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Institute for Prevention and Cancer Epidemiology, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203)
8 University Medicine Greifswald, Institute for Community Medicine, Greifswald, Germany (GRID:grid.461720.6) (ISNI:0000 0000 9263 3446)
9 German Cancer Research Center (DKFZ), Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Division of Preventive Oncology, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584)
10 University Hospital Augsburg, University of Augsburg, Department of Diagnostic and Interventional Radiology, Augsburg, Germany (GRID:grid.7307.3) (ISNI:0000 0001 2108 9006)
11 Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849); Biobank Technology Platform, Max-Delbrueck-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849); Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639)
12 Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Ultrahigh Field Facility (B.U.F.F.), Berlin, Germany (GRID:grid.419491.0) (ISNI:0000 0001 1014 0849)
13 Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639); German Centre for Cardiovascular Research (DZHK), Berlin, Germany (GRID:grid.452396.f) (ISNI:0000 0004 5937 5237); HELIOS Hospital Berlin-Buch, Department of Cardiology and Nephrology, Berlin, Germany (GRID:grid.491869.b) (ISNI:0000 0000 8778 9382)
14 University Hospital Essen, University of Duisburg-Essen, Department of Diagnostic and Interventional Radiology and Neuroradiology, Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445)
15 University Medicine Greifswald, Institute for Community Medicine, Greifswald, Germany (GRID:grid.461720.6) (ISNI:0000 0000 9263 3446); University Medicine Greifswald, German Centre for Cardiovascular Research (DZHK), Partner Site Greifswald, Greifswald, Germany (GRID:grid.5603.0)
16 University Medicine Greifswald, Institute of Diagnostic Radiology and Neuroradiology, Greifswald, Germany (GRID:grid.461720.6) (ISNI:0000 0000 9263 3446)
17 Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Division of Medical Physics, Department of Diagnostic and Interventional Radiology, Freiburg, Germany (GRID:grid.5963.9) (ISNI:0000 0004 0491 7203)
18 Heidelberg University Hospital, Department of Diagnostic and Interventional Radiology, Heidelberg, Germany (GRID:grid.5253.1) (ISNI:0000 0001 0328 4908)